| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/07/2011 | US20110165118 3-heterocyclic substituted indole derivatives and methods of use thereof |
| 07/07/2011 | US20110165117 Immunogenic peptides and methods of use |
| 07/07/2011 | US20110165093 Microbicidal pyrimidine or triazine for preventing sexual hiv transmission |
| 07/07/2011 | US20110165091 Method and composition for delivery of medicants to animals |
| 07/07/2011 | US20110165090 Method and composition for delivery of medicants to animals |
| 07/07/2011 | US20110165081 Psma antibodies and uses thereof |
| 07/07/2011 | US20110165078 Specific binding members against synaptophysin |
| 07/07/2011 | US20110165073 Immunotherapy of b-cell malignancies using anti-cd22 antibodies |
| 07/07/2011 | US20110165071 Methods Of Treating Cancer |
| 07/07/2011 | US20110165068 Liposome medicament, method of preparation and use thereof |
| 07/07/2011 | US20110165066 Interleukin-13 binding proteins |
| 07/07/2011 | US20110165063 Il-1 binding proteins |
| 07/07/2011 | US20110165062 Use of an anti-cd151 antibody for early treatment of cancer |
| 07/07/2011 | US20110162982 Methods for producing vaccine adjuvants |
| 07/07/2011 | CA2789196A1 Anti-iga1 antibody |
| 07/07/2011 | CA2785992A1 Plasmids and methods for peptide display and affinity-selection on virus-like particles of rna bacteriophages |
| 07/07/2011 | CA2785964A1 Anti-cd27 antibody |
| 07/07/2011 | CA2785926A1 Injectable formulations for parenteral administration |
| 07/07/2011 | CA2785909A1 Agonists of tlr4 and 9 receptors for preventing septic complications of post-traumatic immune depression in patients hospitalized for severe trauma |
| 07/07/2011 | CA2785867A1 Production of hemagglutinin-neuraminidase protein in microalgae |
| 07/07/2011 | CA2785810A1 Pythium immunotherapy |
| 07/07/2011 | CA2785607A1 Administration route for a composition to protect an animal against rhodococcus equi |
| 07/07/2011 | CA2783715A1 Novel antibody formulation |
| 07/06/2011 | EP2341348A1 Methods for detecting cross beta structure comprising proteins with crossbeta structure binding compounds. |
| 07/06/2011 | EP2341143A1 OX2 receptor homolog |
| 07/06/2011 | EP2341080A1 Humanized immunoglobulins and their production and use |
| 07/06/2011 | EP2341078A2 Monoclonal antibody against rhesus D |
| 07/06/2011 | EP2341076A2 Thymic stromal lymphopoietin (TSLP) antibodies and uses thereof |
| 07/06/2011 | EP2341075A1 Antibodies binding to the f protein of a respiratory syncytial virus (rsv) |
| 07/06/2011 | EP2341074A1 Antibodies binding to the f protein of a respiratory syncytial virus (rsv) |
| 07/06/2011 | EP2341072A2 Method for Generating Activated T-Cells and Antigen-Pulsed Antigen-Presenting Cells |
| 07/06/2011 | EP2341069A1 Polypeptides from non-typeable haemophilus influenzae |
| 07/06/2011 | EP2341067A1 Specific binding agents to hepatocyte growth factor |
| 07/06/2011 | EP2341063A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/06/2011 | EP2341062A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/06/2011 | EP2341060A1 Molecules with extended half-lives, compositions and uses thereof |
| 07/06/2011 | EP2340851A1 Diagnosis method and therapeutic method for cancer |
| 07/06/2011 | EP2340850A1 Inhibition of factor B, the alternative complement pathway and methods related thereto |
| 07/06/2011 | EP2340849A1 Anti-NGF antibodies for the treatment of various disorders |
| 07/06/2011 | EP2340848A2 Immunogenic compositions of Staphylococcus epidermidis polypeptide and polynucleotide antigens |
| 07/06/2011 | EP2340847A2 Cell populations having immunoregulatory activity, method for isolation and uses |
| 07/06/2011 | EP2340845A2 Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions |
| 07/06/2011 | EP2340262A1 Formulations targeting igfbp7 for diagnosis and therapy of cancer |
| 07/06/2011 | EP2340040A2 Modulation of axon degeneration |
| 07/06/2011 | EP2340039A1 Use of il-20 antagonists for treating rheumatoid arthritis and osteoporosis |
| 07/06/2011 | EP2340038A2 Biochemically stabilized hiv-1 env trimer vaccine |
| 07/06/2011 | EP2340037A1 Methods for determining the levels of tgf- in a composition |
| 07/06/2011 | EP2340036A1 Induction of mucosal immune responses by mucosal delivery pentabody complex (mdpc) |
| 07/06/2011 | EP2339951A1 Device, method and kit for in vivo detection of a biomarker |
| 07/06/2011 | EP1740206B1 Phep, an amino acid permease of staphylococcus aureus |
| 07/06/2011 | EP1730191B1 Immunoglobulin binding hosm |
| 07/06/2011 | EP1587834B1 Uses of il-23 mammalian cytokine; related reagents |
| 07/06/2011 | EP1537146B9 Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections |
| 07/06/2011 | EP1326885B1 Non typeable Haemophilus influenzae BASB201 polypeptides and polynucleotides and uses thereof |
| 07/06/2011 | EP1317283B1 Tweak receptor agonists as anti-angiogenic agents |
| 07/06/2011 | EP1173484B1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains |
| 07/06/2011 | EP1146906B1 Mucosal delivery system |
| 07/06/2011 | CN1934243B Immortalized avian cell lines for virus production |
| 07/06/2011 | CN102119175A Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology |
| 07/06/2011 | CN102119174A Compositions and methods of use for therapeutic antibodies |
| 07/06/2011 | CN102119171A CDCA1 epitope peptides and vaccines containing the same |
| 07/06/2011 | CN102119169A IQGAP3 epitope peptides and vaccines containing the same |
| 07/06/2011 | CN102119155A Process for the preparation of nicotine-based haptens |
| 07/06/2011 | CN102119033A Compositions and methods for enhanced somatostatin immunogenicity |
| 07/06/2011 | CN102119028A Amino alcohol derivatives for the treatment of demyelinating peripheral neuropathies |
| 07/06/2011 | CN102115755A Pichia expression PCV2 (porcine circovirus 2) ORF2 (open reading frame 2) protein and subunit vaccine |
| 07/06/2011 | CN102115729A Method for culturing baby hamster kidney (BHK) 21 cell in serum-free way, and vaccine preparation method |
| 07/06/2011 | CN102115492A Vascular endothelial growth factor receptor partial polypeptide and application thereof |
| 07/06/2011 | CN102114243A Method for preparing polyvalent vaccine of primary hamster kidney cells of flu |
| 07/06/2011 | CN102114242A Tissue inactivation vaccine for bigfoot disease of giant salamander and preparation method thereof |
| 07/06/2011 | CN102114241A Attenuated live vaccine and application thereof |
| 07/06/2011 | CN101955915B Method for producing influenza virus vaccine |
| 07/06/2011 | CN101538327B Anthropogenic H5N1-resisting hemagglutinin protein broad-spectrum neutralising antibody and application thereof |
| 07/06/2011 | CN101455840B Composite capable of strengthening anti-tumor immune response |
| 07/06/2011 | CN101111258B Emulsified composition for dilution and cancer vaccine composition |
| 07/05/2011 | USRE42524 Colloidal metal compositions and methods |
| 07/05/2011 | US7973153 Antigen, nucleic acid encodes fusion protein; polynucleotides; nucleoside sequences |
| 07/05/2011 | US7973143 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 07/05/2011 | US7973142 Antibodies that bind human protein tyrosine phosphatase beta (HPTPβ) |
| 07/05/2011 | US7973139 Antibodies against nogo receptor |
| 07/05/2011 | US7973137 Cell compositions comprising molecular complexes that modify immune responses |
| 07/05/2011 | US7973136 Hodgkin's lymphoma surface protein specific immunoglobulin for use in treatment and prevention of cell proliferative disorders; immunotherapy |
| 07/05/2011 | US7973135 Compositions and methods for targeting cancer-specific transcription complexes |
| 07/05/2011 | US7973048 Pharmaceutical composition |
| 07/05/2011 | US7973007 Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration |
| 07/05/2011 | US7972848 Isolation and identification of cross-reactive T cells |
| 07/05/2011 | US7972845 Human antibodies against Pseudomonas aeruginosa LPS derived from transgenic xenomouse |
| 07/05/2011 | US7972843 DNA-transfection system for the generation of infectious influenza virus |
| 07/05/2011 | US7972814 Antimicrobial polypeptides from Pseudoplectania nigrella |
| 07/05/2011 | US7972661 Electrospraying method with conductivity control |
| 07/05/2011 | US7972629 Product comprising a combination of milk serum apoproteins and free fatty acids |
| 07/05/2011 | US7972611 Fungus-induced inflammation and eosinophil degranulation |
| 07/05/2011 | US7972610 Antimicrobial compounds |
| 07/05/2011 | US7972609 Method of treating cancer |
| 07/05/2011 | US7972608 Carrier proteins for vaccines |
| 07/05/2011 | US7972607 Attenuated francisella and methods of use |
| 07/05/2011 | US7972606 T24 antigen for immunodiagnosis of Taenia solium cysticercosis |
| 07/05/2011 | US7972605 Modified vaccinia ankara virus vaccine |
| 07/05/2011 | US7972604 Recombinant attenuated clostridium organisms and vaccine |
| 07/05/2011 | US7972603 Stable immunogenic product comprising antigenic heterocomplexes |